Skip to content

Absolute Pro 1012538-60Recalls & reported problems

Abbott Vascular Inc. · Absolute Pro Vascular Self-Expanding Stent System 10.0 mm x 60 mm x 135 cm / Over-The-Wire · Class 3 · Implant

Adverse event reports
5
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 08717648176296), received between Sep 14, 2017 and Sep 10, 2024 — classified as 2 injuries, 3 malfunctions.

The most frequently reported specific device problem is “Premature Activation” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 1 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 1 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Premature Activation2
  • Difficult or Delayed Activation1
  • Difficult or Delayed Positioning1
  • Difficult to Remove1
  • Failure to Advance1
  • Material Deformation1
  • Material Separation1
  • Physical Resistance/Sticking1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2
  • Foreign Body In Patient1
  • No Consequences Or Impact To Patient1
  • No Patient Involvement1

Recent adverse event reports

The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.

  • InjurySep 10, 2024Stretched; Material Deformation; Stretched; Material Deformation

    IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A LESION IN THE AV FISTULA. THE 10X60MM ABS PRO SELF EXPANDING STENT SYSTEM (SESS) WAS IMPLANTED AT THE TARGET LESION WITHOUT ISSUE. HOWEVER, AFTER POST DILATATION THE STENT APPEARED TO HAVE SLIGHTLY ELONGATED AND A BUCKLE APPEARED AT A TURN IN THE ARTERY WALL AT A SIDE BRANCH AT THE TARGET LESION. ALTHOUGH, THERE WAS NO ISSUE WITH FLOW OR PATIENT EFFECT, OUT PRECAUTION THE PHYSICIAN DECIDED TO IMPLANT A COVERED STENT IN THE MIDDLE OF THE IMPLANTED ABS PRO STENT TO ENSURE THE STENT WAS ADHERED TO THE VESSEL. THERE WAS NO ADVERSE PATIENT SEQUELA. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20185353 ↗
  • MalfunctionMar 26, 2024Difficult to Remove; Material Separation; Difficult or Delayed Activation; Physical Resistance/Sticking; Difficult to Remove; Material Separation; Difficult or Delayed Activation; Physical Resistance/Sticking

    SUBSEQUENT TO THE INITIALLY FILED MEDWATCH REPORT, ADDITIONAL INFORMATION WAS RECEIVED. IT WAS REPORTED THAT DURING RETRACTION OF THE SES, THE TIP SEPARATED AND BECAME LODGED IN THE SHEATH. THE SEPARATED TIP WAS REMOVED WITH THE SHEATH AND GUIDE WIRE. NO ADDITIONAL INFORMATION WAS PROVIDED..

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18977818 ↗
  • MalfunctionDec 30, 2019Premature Activation; Failure to Advance; Premature Activation; Failure to Advance

    IT WAS REPORTED THAT THE 10 X 60 MM ABSOLUTE PRO VASCULAR STENT WAS UNABLE TO CROSS THE MODERATELY CALCIFIED LESION IN THE SUPERFICIAL FEMORAL ARTERY. DURING REMOVAL OF THE SELF-EXPANDING STENT SYSTEM (SESS), SOME OF THE STENT BECAME PARTIALLY DEPLOYED/FLOWERED. NO ATTEMPT HAD BEEN MADE TO DEPLOY THE STENT AS IT HAD NOT REACHED THE TARGET LESION. THE PHYSICIAN WAS ABLE TO NORMALLY REMOVE THE SESS ALONG WITH THE PARTIALLY DEPLOYED STENT. ANOTHER STENT WAS USED TO COMPLETE THE PROCEDURE. THERE WERE NO ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAY. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 9530409 ↗
  • MalfunctionNov 4, 2019Premature Activation; Premature Activation

    IT WAS REPORTED THAT THE STENT OF A 10X60MM ABSOLUTE PRO SELF-EXPANDING STENT SYSTEM (SESS) WAS UNSHEATHED/EXPOSED TO THE SHEATH WHEN REMOVED FROM THE PACKAGING. THE SESS WAS NOT USED AND THERE WAS NO PATIENT INVOLVEMENT. THE PROCEDURE WAS SUCCESSFULLY COMPLETED WITH A NEW 10X60MM ABSOLUTE PRO SESS. THERE WERE NO ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: No Patient Involvement

    MAUDE report 9273880 ↗
  • InjurySep 14, 2017Difficult or Delayed Positioning

    IT WAS REPORTED THAT THE 10 X 60 MM ABSOLUTE PRO VASCULAR STENT SYSTEM WAS ADVANCED TO THE MILDLY TORTUOUS LEFT COMMON ILIAC ARTERY AND WAS READY FOR STENT DEPLOYMENT, BUT RESISTANCE WAS FELT WITH THE THUMBWHEEL AFTER THE FIRST QUARTER OR HALF TURN OF THE THUMBWHEEL. TROUBLESHOOTING STEPS WERE PERFORMED TO DEPLOY THE STENT, BUT RESISTANCE WAS FELT WITH THE THUMBWHEEL. THE STENT WAS DEPLOYED IN THE NON-TARGET EXTERNAL ILIAC INSTEAD OF THE INTENDED COMMON ILIAC ARTERY. A SECOND SAME SIZE ABSOLUTE PRO VASCULAR STENT WAS SUCCESSFULLY DEPLOYED IN THE TARGET LESION WITHOUT ISSUE. THERE WAS NO REPORTED ADVERSE PATIENT SEQUELA OR A CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: Foreign Body In Patient

    MAUDE report 6867255 ↗

Other STENT, ILIAC devices

All STENT, ILIAC devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.